Around the IP Blogs!
Even when it rains kats and dogs, IPKat wastes no time hibernating. The IP world has been bursting with action during the past week, but IPKat has missed nothing (or nearly so). Enjoy a roundup review of recent cases, events, and once more… echo of Articles 11 and 13 of the Copyright Directive. Patents To resolve the legal uncertainty whether CE-certified devices, i.e. medical device/drug combinations, attract SPC protection, the issue was referred to the CJEU by the German Federal Patent Court. The CJEU in its decision Boston Scientific (C-527/17) of 25 October 2018 ruled that Article 2 of the SPC Regulation must be interpreted to the effect that a CE-mark approval for a medical device comprising an active ingredient as an integral part cannot be equated to an approval in accordance with the Medicinal Products Directives, even if the active ingredient has been analogously assessed by way of the consultation process. Kluwer Patent Blog reports: CJEU shows red card to...